Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Chemoresistance is a common hurdle for the proper treatment of gliomas. The role of Shh-Gli1 signaling in glioma progression has been reported. However, its role in glioma chemoresistance has not been well studied yet. In this work, we found that Shh-Gli1 signaling regulates the expression of one stem cell marker, BMI1 (B cell-specific Moloney murine leukemia virus), in glioma. Interestingly, we also demonstrated high expression of MRP1 (multi-drug resistance protein 1) in glioma. MRP1 expression was decreased by BMI1 siRNA and Shh-Gli1 cell signaling specific inhibitor GANT61 in our experiments. GANT61 very efficiently inhibited cell colony growth in glioma cell lines, compared to temozolomide. Moreover, a synergic effect of GANT61 and temozolomide drastically decreased the LD50 of temozolomide in the cell colony experiments. Therefore, our results suggest that there is a potential nexus of Shh-Gli1-BMI1 cell signaling to regulate MRP1 and to promote chemoresistance in glioma. Henceforth, our study opens the possibility of facing new targets, Gli1 and BMI1, for the effective treatment of glioma suppression of chemoresistance with adjuvant therapy of GANT61 and temozolomide.
Interdisciplinary Brain Research Centre, Faculty of Medicine, Aligarh Muslim University, Aligarh, UP, 202002, India. mehdihayat@gmail.com.
M H
MH
Shahi
Interdisciplinary Brain Research Centre, Faculty of Medicine, Aligarh Muslim University, Aligarh, UP, 202002, India.
S
S
Farheen
Interdisciplinary Brain Research Centre, Faculty of Medicine, Aligarh Muslim University, Aligarh, UP, 202002, India.
M P M
MP
Mariyath
Department of Biochemistry and Genetics, University of Navarra School of Sciences, Irunlarrea 1, 31008, Pamplona, Spain.
J S
JS
Castresana
D017209:Apoptosis; D015153:Blotting, Western; D049109:Cell Proliferation; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D005910:Glioma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics / Q000378:metabolism; D063150:Polycomb Repressive Complex 1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014407:Tumor Cells, Cultured; D000071676:Zinc Finger Protein GLI1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
D053823:Hedgehog Proteins; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D063150:Polycomb Repressive Complex 1; D011725:Pyridines; D011743:Pyrimidines; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D000071676:Zinc Finger Protein GLI1; C069077:BMI1 protein, human; C551027:GANT 61; C400551:GLI1 protein, human; C509239:SHH protein, human; C421109:multidrug resistance-associated protein 1
BMI1; Chemoresistance; GLI1; Glioma; MRP1; Shh
J Neurooncol. 2002 Mar;57(1):27-36
12125964
Front Neurosci. 2015 Jun 16;9:218
26136652
J Neurosci. 2010 Jul 28;30(30):10096-111
20668194
PLoS One. 2012;7(7):e38508
22808009
Curr Stem Cell Res Ther. 2009 Dec;4(4):298-305
19500067
J Biol Chem. 2012 Mar 23;287(13):9962-71
22253443
Nature. 2004 Mar 18;428(6980):337-41
15029199
Cell. 1991 May 31;65(5):737-52
1904008
Development. 1999 Jun;126(14):3089-100
10375501
Stem Cells. 2011 Apr;29(4):700-12
21305672
J Biol Chem. 2002 Feb 15;277(7):5548-55
11719506
Brain Tumor Pathol. 2011 Feb;28(1):1-12
21274750
Oncogene. 2012 Jan 12;31(2):187-99
21685941
Cancer Lett. 2011 Nov 28;310(2):222-31
21803487
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
14645703
Curr Drug Targets. 2014;15(10 ):931-42
25174341
Annu Rev Cell Dev Biol. 2009;25:377-406
19575646
Neuropathol Appl Neurobiol. 2008 Oct;34(5):555-63
18346113
Mol Cell Neurosci. 2010 Oct;45(2):151-62
20600931
J Neurooncol. 2005 Sep;74(2):113-21
16193381
PLoS One. 2014 May 08;9(5):e96593
24810746
BMC Cancer. 2010 Nov 08;10 :614
21059263
Tumour Biol. 2011 Feb;32(1):113-27
20830616
Oncol Rep. 2008 Mar;19(3):681-8
18288402
Cancer Cell. 2007 Oct;12 (4):328-41
17936558
Curr Biol. 2007 Jan 23;17 (2):165-72
17196391
PLoS One. 2015 Jun 25;10 (6):e0131006
26110620